|
|
|
Corporate Social Responsibility Profile
Merck & Co., Inc.
One Merck Drive
P.O. Box 100
Whitehouse Station, NJ 08889-0100
USA
www.merck.com
For More Information Contact
Maggie Kohn
908-423-5655
Description
Merck & Co., Inc. is a global research-driven pharmaceutical company
dedicated to putting patients first. Established in 1891, Merck currently
discovers, develops, manufactures and markets vaccines and medicines to
address unmet medical needs. The Company devotes extensive efforts to
increase access to medicines through far-reaching programs that not only
donate Merck medicines but help deliver them to the people who need them.
Merck also publishes unbiased health information as a not-for-profit
service.
Merck & Co., Inc.: CSR News, Events and Reports
| Category |
Submission Date |
Submission Title |
| News |
11.12.2008 |
Public Health Officials Announce Progress in Elimination of Transmission of the Tropical Disease River Blindness |
| News |
10.27.2008 |
Merck & Co., Inc., Announces New Disclosures in Just-Released Corporate Responsibility Report |
| News |
10.02.2008 |
Merck & Co., Inc. Awards Five Grants to Humanitarian Aid Partners |
| News |
9.18.2008 |
The Merck Manual of Patient Symptoms Empowers a New Generation |
| News |
8.04.2008 |
Merck Institute for Science Education Launches Three-Year Program to Improve Science Teaching in New Jersey and Pennsylvania Public Schools |
| News |
5.20.2008 |
National Society of Black Engineers Honors UNCF/Merck Science Initiative With Golden Torch Award |
| News |
2.20.2008 |
Merck Sets Target to Reduce Global Greenhouse Gas Emissions by 12 Percent |
| News |
11.19.2007 |
Merck Company Foundation Expands Network of Immunization Training Centers in Africa |
| News |
11.15.2007 |
Public Health Officials Announce First Country to Eliminate Transmission of the Tropical Disease Onchocerciasis |
| News |
8.20.2007 |
Recipients of The Merck Index Women in Chemistry Scholarship Announced |
| News |
5.31.2007 |
New Step-by-Step Guidelines Now Available for Developing an HIV/AIDS Prevention and Treatment Program in the African Workplace |
| News |
7.13.2004 |
Merck & Co., Inc. Grants License for HIV/AIDS Drug Efavirenz to South African Company, Thembalami Pharmaceuticals, in Effort to Accelerate Access to Life-Saving Treatment |
| News |
7.10.2000 |
The Bill & Melinda Gates Foundation, Merck & Co., Inc., and The Republic of Botswana Launch New HIV Initiative |
| Reports |
10.27.2008 |
Listening, Responding and Working Toward a Healthier Future |
|
|
|
